Patient death or renal graft loss within 3 yr of transplantation in a county hospital: Importance of poor initial graft function

Clinical Transplantation

Volumn 11, Issue 6, 1997, Pages 618-622

  Shoskes, Daniel A ^a   Avelino, Lori ^a   Barba, Lilly ^a   Sender, Mark ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Immunology; Kidney failure, acute; Kidney transplantation; Reperfusion injury

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 0030658872     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. SIMMONS RG, ANDERSON CR, ABRESS LK. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl 1990: 131: 7.
2. MANNINEN DL, EVANS RW, DUGAN MK. Work disability, functional limitations, the health status of kidney transplantation recipients posttransplant. Clin Transpl 1991: 193.
3. JACOBS C, LUCIANI J. Reappraisal of long-term renal replacement therapy. Renal transplantation: medical versus statistical approach. Blood Purif 1992: 10: 5.
4. MCDONALD JC, AULTMAN DF. Transplantation and quality of care for end-stage renal disease: 1993. Am J Kidney Dis 1994: 24: 362.
5. LAUPACIS A, KEOWN P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996: 50: 235.
6. LE A, WILSON R, DOUEK K, et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994: 24: 65.
7. WILSON RA, NORMAN DJ, BARRY JM, BENNETT WM. Noninvasive cardiac testing in the end-stage renal disease patient. Blood Purif 1994: 12: 78.
8. MANSKE CL, WANG Y, RECTOR T, WILSON RF, WHITE CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992: 340: 998.
9. SHOSKES DA. Urological malignancies in renal transplant recipients. Curr Opin Urol 1995: 5: 91.
10. SHOSKES DA, HALLORAN PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996: 155: 1831.
11. SHOSKES DA, CHURCHILL BM, MCLORIE GA, KHOURY AE. The impact of ischemic and immunologic factors on early graft function in pediatric renal transplantation. Tranplantation 1990: 50: 877.
12. HOWARD RJ, PFAFF WW, BRUNSON ME, et al. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. Transpl Proc 1993: 25: 884.
13. LAND W. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation. Transpl Proc 1994: 26: 3169.
14. SHOSKES DA, PARFREY NA, HALLORAN PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990: 49: 201.
15. SHOSKES DA, HODGE EH, GOORMASTIC M, GOLDFARB DA, NOVICK AC. HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients. Transpl Proc 1995: 27: 1068.
16. ALMOND PS, MATAS A, GILLINGHAM K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993: 55: 752.
17. DAWIDSON I, AR'RAJAB A, DICKERMAN R, et al. Perioperative albumin and verapamil improve early outcome after cadaver renal transplantation. Transpl Proc 1994: 26: 3100.
18. LACHANCE SL, BARRY JM. Effect of furosemide on dialysis requirement following cadaveric kidney transplantation. J Urol 1985: 133: 950.
19. KADIEVA VS, FRIEDMAN L, MARGOLIUS LP, JACKSON SA, MORRELL DF. The effect of dopamine on graft function in patients undergoing renal transplantation. Anesthesia & Analgesia 1993: 76: 362.
20. SHOSKES DA, XIE Y, GONZALES-CADAVID NF. Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat: implications for renal transplantation. Transplantation 1997: 63: 495
21. DUNN J, GOLDEN D, VAN BUREN CT, LEWIS RM, LAWEN J, KAHAN BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990: 49: 349.
22. KILEY DJ, LAM CS, POLLAK R. A study of treatment compliance following kidney transplantation. Transplantation 1993: 55: 51.
23. DE GEEST S, BORGERMANS L, GEMOETS H, et al. Incidence, determinants, consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995: 59: 340.
24. KALIL RS, HEIM-DUTHOY KL, KASISKE BL. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992: 20: 63.
25. MORGENSTERN BZ, MURPHY M, Dayton J, et al. Noncompliance in a pediatric renal transplant population. Transpl Proc 1994: 26: 129.
26. TROPPMANN C, BENEDETTI E, GRUESSNER RW, et al. Retransplantation after renal allograft loss due to noncompliance. Indications, outcome, ethical concerns. Transplantation 1995: 59: 467.